Max Holzer

6.5k total citations · 2 hit papers
89 papers, 5.0k citations indexed

About

Max Holzer is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Max Holzer has authored 89 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Physiology, 40 papers in Molecular Biology and 27 papers in Cellular and Molecular Neuroscience. Recurrent topics in Max Holzer's work include Alzheimer's disease research and treatments (49 papers), Neuroscience and Neuropharmacology Research (20 papers) and Prion Diseases and Protein Misfolding (9 papers). Max Holzer is often cited by papers focused on Alzheimer's disease research and treatments (49 papers), Neuroscience and Neuropharmacology Research (20 papers) and Prion Diseases and Protein Misfolding (9 papers). Max Holzer collaborates with scholars based in Germany, United States and United Kingdom. Max Holzer's co-authors include Thomas Arendt, Jens Stieler, Ulrich Gärtner, Martina K. Brückner, Michel Goedert, Carsten Janke, Dyrk Zedlick, Bernardino Ghetti, Ross Jakes and Molly Craxton and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Max Holzer

88 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein

2002 556 citations Bridget Allen, Takao Masaki et al. Journal of Neuroscience profile →
Tau and tauopathies

2016 428 citations Thomas Arendt, Jens Stieler et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Max Holzer Germany	35	3.1k	2.3k	1.6k	846	720	89	5.0k
Laurent Pradier France	39	2.9k 0.9×	2.6k 1.1×	1.8k 1.1×	777 0.9×	450 0.6×	98	5.2k
Yasuji Matsuoka United States	40	3.2k 1.0×	2.4k 1.0×	1.4k 0.9×	1.1k 1.2×	515 0.7×	80	5.9k
Satyabrata Kar Canada	41	2.8k 0.9×	2.2k 0.9×	1.7k 1.1×	554 0.7×	501 0.7×	118	5.7k
David E. Kang United States	35	3.0k 1.0×	2.3k 1.0×	1.2k 0.7×	684 0.8×	657 0.9×	75	5.3k
Mar Pérez Spain	38	2.8k 0.9×	2.3k 1.0×	1.2k 0.8×	714 0.8×	531 0.7×	81	4.6k
Bryce L. Sopher United States	38	2.1k 0.7×	3.7k 1.6×	2.3k 1.5×	509 0.6×	1.0k 1.4×	63	6.0k
Steffen Roßner Germany	35	2.6k 0.8×	2.0k 0.8×	1.4k 0.9×	814 1.0×	379 0.5×	114	4.9k
Koichi Ishiguro Japan	48	4.0k 1.3×	3.5k 1.5×	2.0k 1.2×	834 1.0×	1.4k 1.9×	94	7.1k
Nikolaos K. Robakis United States	51	4.3k 1.4×	4.1k 1.8×	1.6k 1.0×	845 1.0×	1.1k 1.5×	133	7.3k
Annakaisa Haapasalo Finland	36	2.0k 0.6×	2.1k 0.9×	1.4k 0.9×	862 1.0×	443 0.6×	109	5.3k

Countries citing papers authored by Max Holzer

Since Specialization

Citations

This map shows the geographic impact of Max Holzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Holzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Holzer more than expected).

Fields of papers citing papers by Max Holzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Holzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Holzer. The network helps show where Max Holzer may publish in the future.

Co-authorship network of co-authors of Max Holzer

This figure shows the co-authorship network connecting the top 25 collaborators of Max Holzer. A scholar is included among the top collaborators of Max Holzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Holzer. Max Holzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bullmann, Torsten, Andreas Ritzau‐Jost, Max Holzer, et al.. (2024). Human iPSC-Derived Neurons with Reliable Synapses and Large Presynaptic Action Potentials. Journal of Neuroscience. 44(24). e0971232024–e0971232024. 5 indexed citations

Grunwald, Martin, Jens Stieler, Max Holzer, et al.. (2024). Number of Facial Hair Corresponds to Frequency of Spontaneous Face‐Touch in Humans. Advanced Biology. 9(2). e2400243–e2400243. 1 indexed citations

Peters, Michael H., Dennis Janning, Max Holzer, et al.. (2022). Caspase-cleaved tau is senescence-associated and induces a toxic gain of function by putting a brake on axonal transport. Molecular Psychiatry. 27(7). 3010–3023. 28 indexed citations

Koch, Pierre, et al.. (2021). Evaluation of Novel Substituted Furopyridines as Inhibitors of Protein Kinases Related to Tau Pathology in Alzheimer´s Disease. Medicinal Chemistry. 17(8). 844–855. 4 indexed citations

Hartlage‐Rübsamen, Maike, Isabel Hilbrich, Max Holzer, et al.. (2021). A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies. Acta Neuropathologica. 142(3). 399–421. 19 indexed citations

Lachmann, Ingolf, et al.. (2020). Aggrecan modulates the expression and phosphorylation of tau in a novel bigenic TauP301L ‐ Acan mouse model. European Journal of Neuroscience. 53(12). 3889–3904. 7 indexed citations

Holzer, Max, Andreas Hermann, & Moritz Metelmann. (2019). Therapie der Amyotrophen Lateralsklerose. Nervenheilkunde. 38(6). 402–408.

Rogowski, Krzysztof, Juliette van Dijk, Maria M. Magiera, et al.. (2010). A Family of Protein-Deglutamylating Enzymes Associated with Neurodegeneration. Cell. 143(4). 564–578. 288 indexed citations

Arnold, Erik, et al.. (2009). A putative role for cell cycle‐related proteins in microtubule‐based neuroplasticity. European Journal of Neuroscience. 29(6). 1096–1107. 25 indexed citations

10.

Holzer, Max, et al.. (2007). Long-term results of sealed capsule irrigation using distilled water to prevent posterior capsule opacification: a prospective clinical randomised trial. British Journal of Ophthalmology. 91(7). 912–915. 34 indexed citations

11.

Delobel, Patrice, Isabelle Lavenir, Graham Fraser, et al.. (2007). Analysis of Tau Phosphorylation and Truncation in a Mouse Model of Human Tauopathy. American Journal Of Pathology. 172(1). 123–131. 100 indexed citations

12.

Bullmann, Torsten, Rohan de Silva, Max Holzer, Hiroshi Mori, & Thomas Arendt. (2006). Expression of embryonic tau protein isoforms persist during adult neurogenesis in the hippocampus. Hippocampus. 17(2). 98–102. 51 indexed citations

13.

Allen, Bridget, Takao Masaki, Michael J. Smith, et al.. (2002). Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. PMC. 1 indexed citations

14.

Allen, Bridget, Takao Masaki, Michael J. Smith, et al.. (2002). Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein. Journal of Neuroscience. 22(21). 9340–9351. 556 indexed citations breakdown →

15.

Holzer, Max, et al.. (2002). Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus. Acta Neuropathologica. 104(5). 471–481. 66 indexed citations

16.

Stieler, Jens, Martina K. Brückner, Henrike Wolf, et al.. (2001). Impairment of mitogenic activation of peripheral blood lymphocytes in Alzheimer's disease. Neuroreport. 12(18). 3969–3972. 35 indexed citations

17.

Loibner, Andreas P., Max Holzer, Michael Gartner, Oliver H. J. Szolar, & Rudolf Braun. (2000). The use of sequential supercritical fluid extraction for bioavailability investigations of PAH in soil.. 51(4). 225–233. 12 indexed citations

18.

Gärtner, Ulrich, Max Holzer, & Thomas Arendt. (1999). Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration. Neuroscience. 91(1). 1–5. 82 indexed citations

19.

Arendt, Thomas, et al.. (1998). Phosphorylation of Tau, Aβ-Formation, and Apoptosis After In Vivo Inhibition of PP-1 and PP-2A. Neurobiology of Aging. 19(1). 3–13. 80 indexed citations

20.

Gärtner, Ulrich, Max Holzer, Rolf Heumann, & Thomas Arendt. (1995). Induction of p21ras in Alzheimer pathology. Neuroreport. 6(10). 1441–1444. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact